Insider Transactions Reported by 21 Insiders of BIOCRYST PHARMACEUTICALS INC

Symbol
BCRX on Nasdaq
Location
Durham, NC

Insiders trading volume in the past year

BIOCRYST PHARMACEUTICALS INC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jon P. Stonehouse Chief Executive Officer, Director $11,053,330 19 Dec 2025
Charles K. Gayer President and CCO $3,170,520 19 Dec 2025
Helen M. Thackray Chief R&D Officer $2,829,885 31 Mar 2025
Anthony Doyle Chief Financial Officer $2,792,437 19 Dec 2024
Alane P. Barnes Chief Legal Officer $2,415,303 -$1,493,787 -38% 19 Dec 2025
Babar Ghias Chief Financial Officer $1,929,266 17 Dec 2025
Yarlagadda S. Babu Chief Discovery Officer $1,806,173 14 Nov 2022
Nancy J. Hutson Director $1,025,086 12 Jun 2025
Steven K. Galson Director $732,805 12 Jun 2025
ALAN G. LEVIN Director $664,562 12 Jun 2025
VINCENT MILANO Director $654,952 28 Nov 2025
ROBERT ALEXANDER INGRAM Director $606,198 28 Feb 2023
THERESA HEGGIE Director $556,302 -$595,868 -52% 13 Aug 2025
STEVE ASELAGE Director $469,377 12 Jun 2024
KENNETH B. LEE JR Director $416,621 13 Jun 2023
Amy E. McKee Director $300,052 28 Nov 2025
GEORGE B. ABERCROMBIE Director $235,344 12 Jun 2024
William P. Sheridan Chief Medical Officer $229,622 10 Mar 2022
MACHELLE SANDERS Director $218,783 -$68,544 -24% 13 Nov 2025
Steven Frank Director $126,497 28 Nov 2025
Michael L. Jones Exec. Director, Finance - PAO $100,751 19 Dec 2022

Recent Insider Transactions by Companies or Individuals for BIOCRYST PHARMACEUTICALS INC

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.